Laboratory research suggests apigenin, a plant compound abundant in parsley, may slow cancer progression by interfering with signals tumors use to form blood vessels while causing less damage to healthy tissue.
By yourNEWS Media Newsroom
Parsley, an herb commonly used as a garnish or seasoning, contains a natural compound that researchers say may interfere with one of cancer’s most important survival mechanisms: its ability to create a blood supply.
A study published in Cancer Letters examined apigenin, a plant-based flavonoid found in parsley, and reported that the compound inhibited the growth and spread of aggressive bladder cancer cells.
Researchers found that apigenin appeared to interfere with a vascular endothelial growth factor-related pathway involved in angiogenesis, the process through which tumors stimulate the formation of new blood vessels.
Cancerous growths depend on those vessels to receive oxygen and nutrients. By disrupting the biological signals that promote new vessel development, apigenin may make it more difficult for a tumor to expand and spread.
The findings were particularly notable because the compound reportedly acted against cancerous tissue without producing the same degree of injury to healthy, noncancerous cells.
That distinction is important because many conventional cancer treatments damage rapidly dividing healthy cells along with malignant ones, contributing to side effects involving the digestive tract, immune system, hair follicles and other tissues.
The study focused on bladder cancer, a disease known for recurring after treatment.
As many as 70% of patients may experience a return of the disease after an initial diagnosis and treatment, according to the information provided. That high recurrence rate has led researchers to investigate therapies capable of interfering with several stages of tumor development.
Apigenin’s potential value lies partly in its ability to act on a process tumors require regardless of where they originate.
A growing tumor cannot survive indefinitely on the blood vessels already present in nearby tissue. As it enlarges, it releases chemical signals encouraging the body to construct additional vessels leading directly to the malignant cells.
Vascular endothelial growth factor, commonly abbreviated as VEGF, is one of the principal signaling proteins involved in that process.
Apigenin was reported to suppress a VEGF-related target, reducing the tumor’s ability to stimulate new blood vessel formation.
The mechanism can be compared with interrupting construction of supply routes into a rapidly expanding site. Without sufficient oxygen and nutrients, cancer cells may have greater difficulty multiplying, invading nearby tissue or forming additional tumors elsewhere in the body.
The research does not establish that eating parsley alone can prevent or cure bladder cancer. Laboratory findings involving an isolated compound cannot automatically be translated into a dietary treatment for patients.
Human digestion, absorption, metabolism and dosage can substantially change the effect of a compound compared with controlled laboratory experiments.
The study nevertheless adds to a wider body of research examining apigenin as a possible anticancer agent.
Previous work published in Cancer Prevention Research found that the compound inhibited breast tumor growth, including tumors associated with synthetic hormone replacement therapy.
Researchers have also examined apigenin in connection with other malignancies because of its effects on inflammation, oxidative stress, cell signaling and programmed cell death.
Cancer develops through multiple biological pathways, and compounds capable of influencing several of those processes may be valuable as starting points for future drugs or supportive therapies.
Apigenin is not unique to parsley. It is also found in celery, chamomile and several other fruits, vegetables and herbs, although concentrations vary.
Parsley is among the most familiar dietary sources and can be consumed fresh, dried, blended into sauces or incorporated into salads and other meals.
The herb’s nutritional value extends beyond apigenin.
Parsley contains vitamins K, C and A, along with additional antioxidants and plant compounds. Vitamin K supports normal blood clotting and bone metabolism, while vitamin C contributes to immune function and protection from oxidative damage.
Vitamin A and its plant-based precursors support vision, immune defenses and normal cell growth.
Parsley has also been studied for anti-inflammatory activity. Chronic inflammation is associated with a wide range of medical conditions, including cardiovascular disease, arthritis, metabolic disorders and some cancers.
Antioxidants in the herb help neutralize unstable molecules known as free radicals, which can damage cellular structures when present in excess.
That oxidative damage does not by itself explain every disease, but it can contribute to inflammation, aging and genetic changes affecting normal cell function.
Traditional systems of medicine have used parsley for digestive complaints, fluid retention and kidney support. It has also been consumed as a breath freshener and as a regular ingredient in Mediterranean and Middle Eastern meals.
Those historical uses do not prove modern therapeutic claims, but they have helped direct scientific attention toward compounds present in the plant.
Ancient Greek traditions treated parsley as both a symbolic and medicinal herb. It was used in ceremonial settings, associated with athletic victors and placed at tombs.
Across Europe and the Middle East, parsley later became a familiar culinary and folk remedy.
Lebanese tabbouleh provides one of the clearest examples of parsley being used as a major food rather than a decorative topping. Traditional versions contain substantial amounts of finely chopped parsley combined with tomatoes, grains, lemon juice and other ingredients.
People interested in increasing dietary parsley can add it to salads, soups, grain dishes, smoothies, sauces and pesto-style preparations.
A large handful may also be incorporated into vegetable juice, while fresh leaves can be steeped in hot water to prepare an herbal infusion.
Treating parsley as a principal ingredient rather than a small garnish provides a larger amount of its vitamins and plant compounds.
The research described did not establish a precise amount of parsley that people should consume to reproduce the experimental effects of purified or standardized apigenin.
Clinical dosage cannot be inferred from the concentration used in laboratory cells or animal experiments.
The amount of apigenin absorbed by the human body may also vary depending on preparation, digestive health, other foods consumed and differences among individual plants.
Choosing fresh parsley and washing it thoroughly can reduce exposure to dirt and surface residues. Consumers who prefer organic produce may select it to limit exposure to certain synthetic agricultural chemicals, although organic food should still be washed before use.
Parsley is generally consumed safely in ordinary food amounts, but concentrated products and unusually large quantities may not be appropriate for everyone.
Because parsley is high in vitamin K, people taking warfarin or other medications whose effects depend on stable vitamin K intake should consult a health care professional before significantly changing how much they consume.
Parsley supplements, extracts and essential oils are more concentrated than the herb used in food and may carry different risks.
Pregnant women, people with kidney disorders and those taking prescription medications should seek medical guidance before using concentrated parsley or apigenin products therapeutically.
Cancer patients should not delay surgery, chemotherapy, radiation, immunotherapy or other recommended care in favor of parsley, apigenin or any dietary supplement.
The new findings are best understood as early-stage evidence that may guide additional research rather than proof of an established cancer treatment.
Future studies would need to determine whether apigenin reaches tumors in sufficient concentrations when consumed or administered to people.
Researchers would also need to identify effective doses, potential medication interactions, long-term safety and whether the compound improves survival or lowers recurrence rates in clinical trials.
Another question is whether apigenin might work more effectively when combined with existing treatments.
Some plant compounds can make cancer cells more responsive to chemotherapy or radiation, while others can interfere with medications or alter how the liver processes drugs.
Only carefully controlled studies can determine whether a specific combination is useful or harmful.
The parsley findings contribute to a wider discussion about the role of naturally occurring compounds in medical research.
Many modern medications originated in plants or were developed after scientists identified useful biological activity in natural substances.
Supporters of food-based research argue that more funding should be directed toward compounds that cannot be patented as easily as newly created pharmaceutical molecules.
They contend that inexpensive dietary substances may contain preventive or therapeutic properties that remain insufficiently investigated.
That argument does not mean naturally occurring substances are automatically safer or more effective than prescription drugs.
A compound’s origin does not determine its medical value. Plant-derived substances must still undergo rigorous testing for effectiveness, purity, dosage and safety.
The broader scientific importance of apigenin is that it appears to influence several processes connected to cancer, including inflammation, oxidative stress, blood vessel formation and abnormal cell growth.
Such multi-pathway activity may offer advantages, but it also makes the compound more complicated to study.
BrightU.AI’s Enoch described parsley as “a bright green, biennial herb commonly used as a garnish, seasoning and flavoring agent in a wide variety of cuisines.”
“It belongs to the Apiaceae family and comes in two main varieties: curly leaf and the more robustly flavored flat-leaf (Italian) parsley,” Enoch said. “Beyond its culinary uses, it is a good source of vitamins A, C and K.”
The distinction between curly and flat-leaf parsley is largely culinary. Italian parsley generally has a stronger flavor, while curly parsley is frequently used for decoration, though both varieties provide nutrients and plant compounds.
The Cancer Letters study gives new scientific attention to an ingredient that has often been treated as an afterthought on restaurant plates.
Its findings suggest that apigenin may interfere with the vascular support system bladder tumors need to grow, providing researchers with another possible target for prevention or treatment development.
The work remains preliminary and does not convert parsley into a substitute for oncology care.
It does, however, demonstrate why ordinary foods continue to attract serious scientific investigation.
Parsley’s value may ultimately lie not in a single dramatic cure, but in the collection of vitamins, antioxidants and bioactive compounds it contributes to a varied diet.
Further human trials will be required to determine whether apigenin can be safely developed into a clinical therapy and whether the promising laboratory effects translate into meaningful benefits for people with bladder cancer or other malignancies.
Source: Natural News
Watch and discover the health benefits of parsley.
This video is from the Natural Cures channel on Brighteon.com.
Original article
Comments